High-Dose Eylea’s Improved Durability Could Protect Regeneron’s Market Share

As Roche’s Vabysmo Mounts Threat

 
• By Ayisha Sharma
  
View inside human eye disorders - showing retina, optic nerve and macula.
Eylea Biosimilars Could Reach The Market In 2024 • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Sensory

More from Therapeutic Category